Key result
KCNQ1 G168R variant linked to 100% phenotype penetrance in women and severe arrhythmic risk.
Why the study?
Series analyzing families with the same KCNQ1 pathogenic variants may help develop specific genotype-phenotype management strategies in LQTS.
Observational (n=34)
The KCNQ1 G168R pathogenic variant in Long QT syndrome exhibits high penetrance and significant risk for life-threatening arrhythmic events, particularly in women.
Supports gender-specific penetrance assessment in KCNQ1 variant carriers; leaves open whether tailored screening alters event rates in broader LQTS populations.
Background: Long QT syndrome (LQTS) is an inheritable arrhythmogenic disorder associated with life-threatening arrhythmic events (LAEs). In general, patients with LQTS2 (KCNH2) and LQTS3 (SCN5A) are considered to be a greater risk of LAEs than LQTS1 (KCNQ1) patients. Gender differences are also important. Series analyzing families with the same pathogenic variants may help in the progress of elaborating strong specific genotype-phenotype management strategies. In this manuscript, we describe the phenotype of seven unrelated families, carriers of the KCNQ1 G168R pathogenic variant. Methods: we identified all consecutive index cases referred for genetic testing with LQTS diagnosis carriers of KCNQ1 G168R variant. Genetic and clinical screening for all available relatives was performed. Results: we evaluated seven unrelated families, with a total 34 KCNQ1 G168R carriers (two obligated carriers died without available EKGs to evaluate the phenotype). All index cases but one were women and three of them presented with aborted sudden cardiac death (SCD) or syncope. The presence of sudden death in these families is notable, with a total of nine unexplained sudden deaths and four aborted SCD. Phenotype penetrance was 100% in women and 37.5% in men. Conclusions: KCNQ1 G168R is a pathogenic variant, with a high penetrance among women and mild penetrance among men. Risk for LAEs in this variant seems not negligible, especially among woman, and risk stratification should always be carefully evaluated.
No takes yet. Share an insight, caveat, or question.
Lorca et al. (2020) conducted an observational in Long QT syndrome (LQTS) (n=34). KCNQ1 G168R pathogenic variant was evaluated on Phenotype penetrance. The KCNQ1 G168R pathogenic variant demonstrated 100% phenotype penetrance in women and 37.5% in men, with a notable risk for life-threatening arrhythmic events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: